Equetro Web Pages Omit Risk Info, Make Unsupported Claims On Depression, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency sent Validus Pharmaceuticals a letter objecting to web pages that minimize the risk of suicidality with use of the bipolar disorder drug and suggest it does not worsen depression or induce weight gain.